GLP has been found to be elevated in a few cancers such as breast, lung, gastric, and ovarian cancers whereas G9a is frequently overexpressed in many cancers including breast, lung, ovarian, prostate, colon, bladder, and hepatocellular cancers [85]. Here, EHMT2 is linked to cancer.